Role of platelet electron microscopy in the diagnosis of platelet disorders

Seminars in Thrombosis and Hemostasis

Volumn 35, Issue 2, 2009, Pages 213-223

  Clauser, Sylvain ^a,b   Cramer Bordé, Elisabeth ^a,c  

^a HÔPITAL AMBROISE PARÉ   (France)

^b LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^c INSTITUT COCHIN   (France)

Author keywords

Diagnosis; Electron; Microscopy; Platelet

Indexed keywords

BERNARD SOULIER DISEASE; CELL MEMBRANE; CELL ORGANELLE; CHEDIAK HIGASHI SYNDROME; CYTOSKELETON; DELTA STORAGE POOL DISEASE; DIGEORGE SYNDROME; DISEASE CLASSIFICATION; FECHTNER SYNDROME; GRAY THROMBOCYTE SYNDROME; HUMAN; JACOBSEN SYNDROME; MAY HEGGLIN ANOMALY; MEDITERRANEAN MACROTHROMBOCYTOPENIA; NEPHROTIC SYNDROME; OCULAR ALBINISM; PLATELET SPHEROCYTOSIS; PRIORITY JOURNAL; QUEBEC PLATELET DISORDER; REVIEW; SEBASTIAN SYNDROME; THROMBOCYTE DISORDER; THROMBOCYTE STRUCTURE; THROMBOCYTOPENIA; TRANSMISSION ELECTRON MICROSCOPY; VELOCARDIOFACIAL SYNDROME; WISKOTT ALDRICH SYNDROME; X LINKED THROMBOCYTOPENIA; BLOOD; METABOLISM; METHODOLOGY; THROMBOCYTE; ULTRASTRUCTURE;

BLOOD PLATELET DISORDERS; BLOOD PLATELETS; HUMANS; MICROSCOPY, ELECTRON, TRANSMISSION;

EID: 69249219312     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0029-1220329     Document Type: Review

References (90)

1. Balduini CL, Cattaneo M, Fabris F, et al; Italian Gruppo di Studio delle Piastrine. Inherited thrombocytopenias: a proposed diagnostic algorithm from the Italian Gruppo di Studio delle Piastrine. Haematologica 2003;88:582-592
2. Raccuglia G. Gray platelet syndrome. A variety of qualitative platelet disorder. Am J Med 1971;51:818-828
3. Jantunen E, Hánninen A, Naukkarinen A, Vornanen M, Lahtinen R. Gray platelet syndrome with splenomegaly and signs of extramedullary hematopoiesis: a case report with review of the literature. Am J Hematol 1994;46:218-224 (Pubitemid 24206748)
4. Kóhler M, Hellstern P, Morgenstern E, et al. Gray platelet syndrome: selective alpha-granule deficiency and thrombocytopenia due to increased platelet turnover. Blut 1985;50:331-340 (Pubitemid 15009733)
5. Martínez-Murillo C, Payns Borrego E, Arzate Hernández G, et al. [Gray-platelet syndrome associated with Marfan disease in a Mexican family]. Sangre (Barc) 1994;39:287-291
6. Drouin A, Favier R, Massé JM, et al. Newly recognized cellular abnormalities in the gray platelet syndrome. Blood 2001;98:1382-1391
7. White JG. Ultrastructural studies of the gray platelet syndrome. Am J Pathol 1979;95:445-462
8. Levy-Toledano S, Caen JP, Breton-Gorius J, et al. Gray platelet syndrome: alpha-granule deficiency. Its influence on platelet function. J Lab Clin Med 1981;98:831-848 (Pubitemid 12253328)
9. Gerrard JM, Phillips DR, Rao GH, et al. Biochemical studies of two patients with the gray platelet syndrome. Selective deficiency of platelet alpha granules. J Clin Invest 1980;66:102-109
10. Nurden AT, Kunicki TJ, Dupuis D, Soria C, Caen JP. Specific protein and glycoprotein deficiencies in platelets isolated from two patients with the gray platelet syndrome. Blood 1982;59:709-718
11. Breton-Gorius J, Vainchenker W, Nurden A, Levy-Toledano S, Caen J. Defective alpha-granule production in megakaryocytes from gray platelet syndrome: ultrastructural studies of bone marrow cells and megakaryocytes growing in culture from blood precursors. Am J Pathol 1981;102:10-19 (Pubitemid 11142811)
12. Cramer EM, Vainchenker W, Vinci G, Guichard J, Breton-Gorius J. Gray platelet syndrome: immunoelectron microscopic localization of fibrinogen and von Willebrand factor in platelets and megakaryocytes. Blood 1985;66:1309-1316 (Pubitemid 16194692)
13. Rosa JP, George JN, Bainton DF, Nurden AT, Caen JP, McEver RP. Gray platelet syndrome. Demonstration of alpha granule membranes that can fuse with the cell surface. J Clin Invest 1987;80:1138-1146
14. Favier R, Douay L, Esteva B, et al. A novel genetic thrombocytopenia (Paris-Trousseau) associated with platelet inclusions, dysmegakaryopoiesis and chromosome deletion AT 11q23. C R Acad Sci III 1993;316:698-701 (Pubitemid 23288745)
15. Breton-Gorius J, Favier R, Guichard J, et al. A new congenital dysmegakaryopoietic thrombocytopenia (Paris-Trousseau) associated with giant platelet alpha-granules and chromosome 11 deletion at 11q23. Blood 1995;85:1805-1814
16. Krishnamurti L, Neglia JP, Nagarajan R, et al. Paris-Trousseau syndrome platelets in a child with Jacobsen's syndrome. Am J Hematol 2001;66:295-299 (Pubitemid 32210300)
17. Pivnick EK, Velagaleti GV, Wilroy RS, et al. Jacobsen syndrome: report of a patient with severe eye anomalies, growth hormone deficiency, and hypothyroidism associated with deletion 11 (q23q25) and review of 52 cases. J Med Genet 1996;33:772-778
18. Grossfeld PD, Mattina T, Lai Z, et al. The 11q terminal deletion disorder: a prospective study of 110 cases. Am J Med Genet A 2004;129A:51-61 (Pubitemid 38989044)
19. Hayward CP, Rivard GE, Kane WH, et al. An autosomal dominant, qualitative platelet disorder associated with multimerin deficiency, abnormalities in platelet factor V, thrombospondin, von Willebrand factor, and fibrinogen and an epinephrine aggregation defect. Blood 1996;87:4967-4978 (Pubitemid 26189838)
20. Kahr WH, Zheng S, Sheth PM, et al. Platelets from patients with the Quebec platelet disorder contain and secrete abnormal amounts of urokinase-type plasminogen activator. Blood 2001;98:257-265
21. Tracy PB, Giles AR, Mann KG, Eide LL, Hoogendoorn H, Rivard GE. Factor V (Quebec): a bleeding diathesis associated with a qualitative platelet factor V deficiency. J Clin Invest 1984;74:1221-1228
22. Hayward CP, Bainton DF, Smith JW, et al. Multimerin is found in the alpha-granules of resting platelets and is synthesized by a megakaryocytic cell line. J Clin Invest 1993;91:2630-2639
23. Hayward CP, Cramer EM, Kane WH, et al. Studies of a second family with the Quebec platelet disorder: evidence that the degradation of the alpha-granule membrane and its soluble contents are not secondary to a defect in targeting proteins to alpha-granules. Blood 1997;89:1243-1253
24. Veljkovic DK, Rivard GE, Diamandis M, Blavignac J, Cramer-Borde EM, Hayward CP. Increased expression of urokinase plasminogen activator in Quebec platelet disorder is linked to megakaryocyte differentiation. Blood 2009;113:1535-1542
25. Diamandis M, Paterson AD, Rommens JM, et al. Quebec platelet disorder is linked to the urokinase plasminogen activator gene (PLAU) and increases expression of the linked allele in megakaryocytes. Blood 2009;113:1543-1546
26. Nieuwenhuis HK, Akkerman JW, Sixma JJ. Patients with a prolonged bleeding time and normal aggregation tests may have storage pool deficiency: studies on one hundred six patients. Blood 1987;70:620-623
27. Holmsen H, Weiss HJ. Hereditary defect in the platelet release reaction caused by a deficiency in the storage pool of platelet adenine nucleotides. Br J Haematol 1970;19:643-649
28. Holmsen H, Weiss HJ. Further evidence for a deficient storage pool of adenine nucleotides in platelets from some patients with thrombocytopathia - "storage pool disease". Blood 1972;39:197-209
29. Lages B, Scrutton MC, Holmsen H, Day HJ, Weiss HJ. Metal ion contents of gel-filtered platelets from patients with storage pool disease. Blood 1975;46:119-130
30. Weiss HJ, Witte LD, Kaplan KL, et al. Heterogeneity in storage pool deficiency: studies on granule-bound substances in 18 patients including variants deficient in alpha-granules, platelet factor 4, beta-thromboglobulin, and platelet-derived growth factor. Blood 1979;54:1296-1319
31. Israels SJ, McNicol A, Robertson C, Gerrard JM. Platelet storage pool deficiency: diagnosis in patients with prolonged bleeding times and normal platelet aggregation. Br J Haematol 1990;75:118-121 (Pubitemid 20157990)
32. Weiss HJ, Ames RP. Ultrastructural findings in storage pool disease and aspirin-like defects of platelets. Am J Pathol 1973;71:447-466
33. McNicol A, Israels SJ, Robertson C, Gerrard JM. The empty sack syndrome: a platelet storage pool deficiency associated with empty dense granules. Br J Haematol 1994;86:574-582 (Pubitemid 24199047)
34. Hermansky F, Pudlak P. Albinism associated with hemorrhagic diathesis and unusual pigmented reticular cells in the bone marrow: report of two cases with histochemical studies. Blood 1959;14:162-169
35. Di Pietro SM, Falcón-Pérez JM, Tenza D, et al. BLOC-1 interacts with BLOC-2 and the AP-3 complex to facilitate protein trafficking on endosomes. Mol Biol Cell 2006;17:4027-4038 (Pubitemid 44330885)
36. Hardisty RM, Hutton RA. Bleeding tendency associated with "new" abnormality of platelet behaviour. Lancet 1967;1:983-985
37. Maurer HM, Wolff JA, Buckingham S, Spielvogel AR. "Impotent" platelets in albinos with prolonged bleeding times. Blood 1972;39:490-499
38. White JG, Edson JR, Desnick SJ, Witkop CJ Jr. Studies of platelets in a variant of the Hermansky-Pudlak syndrome. Am J Pathol 1971;63:319-332
39. Witkop CJ, Krumwiede M, Sedano H, White JG. Reliability of absent platelet dense bodies as a diagnostic criterion for Hermansky-Pudlak syndrome. Am J Hematol 1987;26:305-311 (Pubitemid 18008820)
40. Chediak MM. [New leukocyte anomaly of constitutional and familial character]. Rev Hematol 1952;7:362-367
41. Higashi O. Congenital gigantism of peroxidase granules; the first case ever reported of qualitative abnormity of peroxidase. Tohoku J Exp Med 1954;59:315-332
42. Sato A. Chédiak and Higashi's disease: probable identity of a new leucocytal anomaly (Chédiak) and congenital gigantism of peroxidase granules (Higashi). Tohoku J Exp Med 1955;61:201-210
43. Introne W, Boissy RE, Gahl WA. Clinical, molecular, and cell biological aspects of Chediak-Higashi syndrome. Mol Genet Metab 1999;68:283-303 (Pubitemid 29501101)
44. White JG. The Chediak-Higashi syndrome: a possible lysosomal disease. Blood 1966;28:143-156
45. Apitz-Castro R, Cruz MR, Ledezma E, et al. The storage pool deficiency in platelets from humans with the Chédiak-Higashi syndrome: study of six patients. Br J Haematol 1985;59:471-483 (Pubitemid 15132947)
46. Rendu F, Breton-Gorius J, Lebret M, et al. Evidence that abnormal platelet functions in human Chédiak-Higashi syndrome are the result of a lack of dense bodies. Am J Pathol 1983;111:307-314
47. White JG. Platelet microtubules and giant granules in the Chediak-Higashi syndrome. Am J Med Technol 1978;44:273-278
48. Althaus K, Greinacher A. MYH9-related platelet disorders. Semin Thromb Hemost 2009;35:189-203
49. May R. Leukozyteneinschlússe. Deutsch Arch Klin Med 1909;96:1-6
50. Hegglin R. Gleichzeitige konstitutionelle veránderungen an neutrophilen und thrombozyten. Helvet Med Acta-Series A 1945;4/5:439-440
51. Jordan SW, Larsen WE. Ultrastructural studies of the May-Hegglin anomaly. Blood 1965;25:921-932
52. Peterson LC, Rao KV, Crosson JT, White JG. Fechtner syndrome - a variant of Alport's syndrome with leukocyte inclusions and macrothrombocytopenia. Blood 1985;65:397-406
53. Greinacher A, Nieuwenhuis HK, White JG. Sebastian platelet syndrome: a new variant of hereditary macrothrombocytopenia with leukocyte inclusions. Blut 1990;61:282-288
54. Seri M, Cusano R, Gangarossa S, et al; The May-Heggllin/Fechtner Syndrome Consortium. Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes. Nat Genet 2000;26:103-105
55. Seri M, Savino M, Bordo D, et al. Epstein syndrome: another renal disorder with mutations in the nonmuscle myosin heavy chain 9 gene. Hum Genet 2002;110:182-186 (Pubitemid 36067436)
56. Seri M, Pecci A, Di Bari F, et al. MYH9-related disease: May-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome are not distinct entities but represent a variable expression of a single illness. Medicine (Baltimore) 2003;82:203-215 (Pubitemid 36578709)
57. Deutsch S, Rideau A, Bochaton-Piallat ML, et al. Asp1424Asn MYH9 mutation results in an unstable protein responsible for the phenotypes in May-Hegglin anomaly/Fechtner syndrome. Blood 2003;102:529-534 (Pubitemid 36841971)
58. Marigo V, Nigro A, Pecci A, et al. Correlation between the clinical phenotype of MYH9-related disease and tissue distribution of class II nonmuscle myosin heavy chains. Genomics 2004;83:1125-1133 (Pubitemid 38728990)
59. Lusher JM, Schneider J, Mizukami I, Evans RK. The May-Hegglin anomaly: platelet function, ultrastructure and chromosome studies. Blood 1968;32:950-961
60. Volpe E, Cuccurullo L, Valente A, Jori GP, Buonanno G. The May-Hegglin anomaly. Further studies on leukocyte inclusions and platelet ultrastructure. Acta Haematol 1974;52:238-247
61. White JG, Sauk JJ. The organization of microtubules and microtubule coils in giant platelet disorders. Am J Pathol 1984;116:514-522
62. Noris P, Spedini P, Belletti S, Magrini U, Balduini CL. Thrombocytopenia, giant platelets, and leukocyte inclusion bodies (May-Hegglin anomaly): clinical and laboratory findings. Am J Med 1998;104:355-360 (Pubitemid 28211026)
63. Pujol-Moix N, Kelley MJ, Hernández A, Muñiz-Diaz E, Español I. Ultrastructural analysis of granulocyte inclusions in genetically confirmed MYH9-related disorders. Haematologica 2004;89:330-337 (Pubitemid 38788419)
64. Notarangelo LD, Miao CH, Ochs HD. Wiskott-Aldrich syndrome. Curr Opin Hematol 2008;15:30-36
65. Bosticardo M, Marangoni F, Aiuti A, Villa A, Roncarolo MG. Recent advances in understanding the pathophysiology of Wiskott-Aldrich syndrome. Blood 2009; April 7 (Epub ahead of print)
66. Derry JM, Ochs HD, Francke U. Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. Cell 1994;78:635-644 (Pubitemid 24268586)
67. Villa A, Notarangelo L, Macchi P, et al. X-linked thrombocytopenia and Wiskott-Aldrich syndrome are allelic diseases with mutations in the WASP gene. Nat Genet 1995;9:414-417
68. Symons M, Derry JM, Karlak B, et al. Wiskott-Aldrich syndrome protein, a novel effector for the GTPase CDC42Hs, is implicated in actin polymerization. Cell 1996;84:723-734 (Pubitemid 26094202)
69. Gróttum KA, Hovig T, Holmsen H, Abrahamsen AF, Jeremic M, Seip M. Wiskott-Aldrich syndrome: qualitative platelet defects and short platelet survival. Br J Haematol 1969;17:373-388
70. Baldini MG. Nature of the platelet defect in the Wiskott-Aldrich syndrome. Ann N Y Acad Sci 1972;201:437-444
71. Marone G, Albini F, di Martino L, Quattrin S, Poto S, Condorelli M. The Wiskott-Aldrich syndrome: studies of platelets, basophils and polymorphonuclear leucocytes. Br J Haematol 1986;62:737-745 (Pubitemid 16129171)
72. Haddad E, Cramer E, Rivière C, et al. The thrombocytopenia of Wiskott Aldrich syndrome is not related to a defect in proplatelet formation. Blood 1999;94:509-518 (Pubitemid 29323865)
73. Dixon RE, Davis WE, Benbow JB, Kremer WB. Spherical platelet syndrome: absent microtubules and a bleeding diathesis. Clin Res 1974;22:388A
74. Schneider W, Morgenstern E, Reimers HJ. Disassembly of microtubules in the Lesch-Nyhan syndrome? (Lesch-Nyhan syndrome and microtubules) Klin Wochenschr 1979;57:181-186
75. White JG, de Alarcon PA. Platelet spherocytosis: a new bleeding disorder. Am J Hematol 2002;70:158-166
76. Bernard J, Soulier JP. Sur une nouvelle variété de dystrophie thrombocytaire-hémorragipare congénitale. Sem Hop Paris 1948;24:3217-3223
77. López JA, Andrews RK, Afshar-Kharghan V, Berndt MC. Bernard-Soulier syndrome. Blood 1998;91:4397-4418
78. De Marco L, Mazzucato M, Fabris F, et al. Variant Bernard-Soulier syndrome type bolzano. A congenital bleeding disorder due to a structural and functional abnormality of the platelet glycoprotein Ib-IX complex. J Clin Invest 1990;86:25-31 (Pubitemid 20226970)
79. Smith TP, Dodds WJ, Tartaglia AP. Thrombasthenicthrombopathic thrombocytopenia with giant, "Swiss-cheese" platelets. A case report. Ann Intern Med 1973;79:828-834
80. Maldonado JE, Gilchrist GS, Brigden LP, Bowie EJ. Ultrastructure of platelets in Bernard-Soulier syndrome. Mayo Clin Proc 1975;50:402-406
81. White JG, Gerrard JM. Ultrastructural features of abnormal blood platelets. A review. Am J Pathol 1976;83:589-632
82. Hourdillé P, Pico M, Jandrot-Perrus M, LacazeD, Lozano M, Nurden AT. Studies on the megakaryocytes of a patient with the Bernard-Soulier syndrome. Br J Haematol 1990;76:521-530
83. Ware J, Russell S, Ruggeri ZM. Generation and rescue of a murine model of platelet dysfunction: the Bernard-Soulier syndrome. Proc Natl Acad Sci U S A 2000;97:2803-2808 (Pubitemid 30159252)
84. Cunningham JG, Meyer SC, Fox JE. The cytoplasmic domain of the alpha-subunit of glycoprotein (GP) Ib mediates attachment of the entire GP Ib-IX complex to the cytoskeleton and regulates von Willebrand factor-induced changes in cell morphology. J Biol Chem 1996;271:11581-11587 (Pubitemid 26156005)
85. Behrens WE. Mediterranean macrothrombocytopenia. Blood 1975;46:199-208
86. Savoia A, Balduini CL, Savino M, et al. Autosomal dominant macrothrombocytopenia in Italy is most frequently a type of heterozygous Bernard-Soulier syndrome. Blood 2001;97:1330-1335 (Pubitemid 32183756)
87. Kobrynski LJ, Sullivan KE. Velocardiofacial syndrome, DiGeorge syndrome: the chromosome 22q11.2 deletion syndromes. Lancet 2007;370:1443-1452
88. Liang HP, Morel-Kopp MC, Curtin J, et al. Heterozygous loss of platelet glycoprotein (GP) Ib-V-IX variably affects platelet function in velocardiofacial syndrome (VCFS) patients. Thromb Haemost 2007;98:1298-1308 (Pubitemid 350239102)
89. Budarf ML, Konkle BA, Ludlow LB, et al. Identification of a patient with Bernard-Soulier syndrome and a deletion in the DiGeorge/velo-cardio-facial chromosomal region in 22q11.2. Hum Mol Genet 1995;4:763-766
90. Richards JG, Da Prada M. Uranaffin reaction: a new cytochemical technique for the localization of adenine nucleotides in organelles storing biogenic amines. J Histochem Cytochem 1977;25:1322-1326 (Pubitemid 8245641)